Biologics for severe nasal polyps: a French registry study
Part of Ear, nose & throat, Lungs & breathing clinical trials.
This study follows patients in France who are receiving biologic treatments for severe nasal polyps with chronic sinusitis. It collects information on how well these treatments work and their side effects over time.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older
- You have severe nasal polyps with chronic sinusitis and need a biologic treatment approved for this condition
- You have not taken oral steroids in the past month
- You have not used any biologic treatment for inflammatory diseases (other than for severe asthma or your nasal condition) in the past 6 months
- You do not have a history of allergic reaction to humanized antibodies
- You have not had COVID-19 with lasting smell problems in the last 3 months
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial compares three different biologic medications (injectable drugs) to see which one works best for people with chronic sinusitis and nasal polyps. If you have moderate to severe symptoms and are considering biologic therapy, this study might help find the best option for you.
This study looks at patients with nasal polyps and chronic sinusitis who have been stable on a biologic medicine (Dupilumab or Mepolizumab) for at least 3 months. It checks if they stay in remission (symptoms well controlled, no need for extra treatments) for a full year.
This trial studies whether dupilumab (an injection) can reduce staph bacteria in the nose and make the nose’s microbes more diverse in adults with chronic rhinosinusitis with nasal polyps (CRSwNP). If you already have a plan to start dupilumab as standard care, the study may help doctors better understand why it works.
This trial tests a new antibody medicine (depemokimab) for Japanese adults with chronic sinusitis and nasal polyps. It aims to see if the drug alone can reduce symptoms without needing steroid nasal sprays.
This study follows people with chronic rhinosinusitis and nasal polyps who are starting a biologic medication (omalizumab, mepolizumab, or dupilumab) to see how well it works in real life.
This study looks at how “biologic” medicines work in real-life care for people with severe chronic rhinosinusitis with nasal polyps (CRSwNP). It may help confirm which patients benefit and how treatment is used in everyday practice.
Hear when a new Nasal Polyps trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.